Linagliptin and Empagliflozin Inhibit Microtubule Affinity Regulatory Kinase 4: Repurposing Anti-Diabetic Drugs in Neurodegenerative Disorders Using In Silico and In Vitro Approaches.

The entire trajectory can be partitioned into two phases: in the first 100 ns, the RMSD slightly shows an increasing trend whereby the sidechains adapt to each other’s movements, and there are global conformational changes expected as the protein–ligand complexes adapt to the binding event.

also in 63,971 other papers